A multiscale approach for bridging the gap between potency, efficacy, and safety of small molecules directed at membrane proteins
Abstract Membrane proteins constitute a substantial fraction of the human proteome, thus representing a vast source of therapeutic drug targets. Indeed, newly devised technologies now allow targeting “undruggable” regions of membrane proteins to modulate protein function in the cell. Despite the adv...
Guardado en:
Autores principales: | Rodrigo Aguayo-Ortiz, Jeffery Creech, Eric N. Jiménez-Vázquez, Guadalupe Guerrero-Serna, Nulang Wang, Andre Monteiro da Rocha, Todd J. Herron, L. Michel Espinoza-Fonseca |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/39ac1d8d1b97427ba94cce0ca3901e15 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bridging the Gap in a Rare Cause of Angina
por: Sumanth Khadke, et al.
Publicado: (2021) -
Insulators for 2D nanoelectronics: the gap to bridge
por: Yury Yu. Illarionov, et al.
Publicado: (2020) -
Bridging the Gap: Greater Usability for TEI encoding
por: Stefan Dumont, et al.
Publicado: (2015) -
Bridging the gap from academia to humanitarian project management
por: K. Delaney, et al.
Publicado: (2016) -
Fracture prevention service to bridge the osteoporosis care gap
por: Ruggiero C, et al.
Publicado: (2015)